Study design multiple dose stuy - circadian PK [Design Issues]

posted by Summertime – Slovenia, 2020-03-26 17:29 (297 d 18:15 ago) – Posting: # 21301
Views: 951

Hi to all.

My question is related to below Helmuts post:

» » A case of Steady state bioequivalence study in which dose is administered twice daily from Day XX to Day XX. Suppose Day 01 to Day 07 where on day 07 only morning dose will be administered.
»
» This is only acceptable if you know that there are no circadian differences in PK. Otherwise, you have to administer both doses on day 7 as well and assess the complete 24 hours profile.

Is this really necessary also for non-pulsatile modified-release forms (especially when efficacy is not compromised due to circadian differences in PK)? I see many challenges in this approach - especially I find it very volunteer unfriendly, as relatively intense blood sampling would be done also during the night.
Helmut, is this your personal opinion what would be the most right thing to do or you came across that demand/opinion form regulatory authorities? Would highly appreciate your explanation.

Thanks in advance,
Summertime

Complete thread:

Activity
 Admin contact
21,303 posts in 4,441 threads, 1,487 registered users;
online 12 (0 registered, 12 guests [including 8 identified bots]).
Forum time: Monday 11:45 CET (Europe/Vienna)

I believe there is no philosophical high-road in science,
with epistemological signposts. No, we are in a jungle
and find our way by trial and error,
building our road behind us as we proceed.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5